Yes, clear progress but the announcement could have done with a few numbers. Start-up firms like Microba have no excuse for being opaque and tardy in their reporting / disclosures. It is all well and good to sign multiple distribution deals but it is sales and profit margins, actuals and projections, that will be the making or breaking of this company imo. Hopefully the quarterly is more transparent.
Ann: Microba, SYNLAB Extend & Expand Distribution, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
9.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $47.38M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30000 | 9.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.5¢ | 114482 | 1 |
View Market Depth
| Last trade - 09.59am 30/07/2025 (20 minute delay) ? |
| MAP (ASX) Chart |
Day chart unavailable